DRNA - Dicerna Pharmaceuticals Stock Trading

Dicerna Pharmaceuticals Inc.(NASDAQ: DRNA) stock trading, description, contact, officers and directors.

About Dicerna Pharmaceuticals Inc.

Not available

Stock Information

Dicerna Pharmaceuticals Inc. Company Name:

DRNA Stock Symbol:

NASDAQ Market:

DRNA - Dicerna Pharmaceuticals Stock Trading

Get DRNA Alerts

News, Short Squeeze, Breakout and More Instantly...

DRNA - Dicerna Presents Positive New Interim Data From PHYOX(TM)3 Long-Term, Open-Label Extension Study of Nedosiran for Treatment of Primary Hyperoxaluria (PH)

– All Participants Receiving Nedosiran, Regardless of Subtype, Achieved Normalization or Near-Normalization of Urinary Oxalate, a Key PH Measure, by Day 180 in Ongoing, Open-Label Trial – – Nedosiran Was Generally Well Tolerated With No Serious Safety Conc...
DRNA - Dicerna to Participate in the H.C. Wainwright Hepatitis B Virus (HBV) Mini-Conference

Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that Douglas M. Fambrough, Ph.D., president and chief executive officer, w...
DRNA - VBL Therapeutics Announces Appointment of Marc Kozin as Vice Chairman of Board of Directors

TEL AVIV, Israel, Oct. 13, 2020 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ) today announced that it has appointed Marc Kozin as Vice Chairman of the Board. Mr. Kozin will transition to becoming Chairman during 2021, at which time Bennett Shapiro, M.D., the current Chairman of t...